Evaluation of the effect of nut consumption on energy balance, metabolic, inflammatory response and oxidation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN36468613

Enrollment

Registered

2006-06-19

Start date

2006-01-08

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome Nutritional, Metabolic, Endocrine Metabolic syndrome

Interventions

Participants are randomly assigned into two equal groups: 1. Control group: low-fat diet according to American Heart Association guidelines 2. Nut group: low-fat diet according to American Heart Assoc

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with metabolic syndrome aged between 18 and 65 years

Exclusion criteria

Exclusion criteria: 1. Nut allergy 2. Type 2 diabetes 3. Body mass index (BMI) >33 kg/m^2 4. Secondary obesity 5. Inflammatory or infectious disease 6. Anti-inflammatory or antibiotic drugs 7. Alcoholism or drug abuse 8. Recent hypocaloric diet

Design outcomes

Primary

Measure	Time frame
Peripheral inflammatory markers	—

Secondary

Measure	Time frame
1. Stress oxidative markers 2. Endothelial function 3. Insulin sensitivity 4. Energy balance	—

Countries

Spain

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 10, 2026